MedTrace Logo

Nicotine Patch Pretreatment for Smoking Cessation in PTSD

NCT00625131 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 87

Last updated 2014-11-20

Study results available
· View outcomes & findings →

Summary

This study seeks to evaluate the relationship between PTSD, abstinence, and factors associated with relapse in the context of a randomized, clinical smoking cessation trial.

Conditions

  • Stress Disorders, Posttraumatic
  • Tobacco Use Disorder

Interventions

DRUG

Nicotine

Delivered through transdermal nicotine patch

BEHAVIORAL

Cognitive Behavioral Therapy for Smoking Cessation

Manualized protocol for CBT in smoking cessation

DRUG

Bupropion Sustained Release (SR)

Antidepressant

DRUG

Placebo patch

Pre-treatment placebo transdermal patch

Sponsors & Collaborators

Principal Investigators

  • Jean C. Beckham, PhD · VA Medical Center, Durham

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00625131 on ClinicalTrials.gov